EUVIMEDEUVIMED entdecken
Crossref

Real-World Effectiveness of Anti–PD-1 Immunotherapy Combined with Definitive Chemoradiotherapy in Inoperable ESCC: A Multicenter Weighted Analysis

Wei Chen, Li Zhang

Asian Journal of Current Research in Clinical Cancer · 2025 · 5 (1) · 232-242

DOI: 10.51847/ea665c6fiw ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Current Research in Clinical Cancer, 2025. Verfasst von Wei Chen und 1 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chen, W., & Zhang, L. (2025). Real-World Effectiveness of Anti–PD-1 Immunotherapy Combined with Definitive Chemoradiotherapy in Inoperable ESCC: A Multicenter Weighted Analysis. Asian Journal of Current Research in Clinical Cancer, 5(1), 232-242. https://doi.org/10.51847/ea665c6fiw

Vancouver

Chen W, Zhang L. Real-World Effectiveness of Anti–PD-1 Immunotherapy Combined with Definitive Chemoradiotherapy in Inoperable ESCC: A Multicenter Weighted Analysis. Asian Journal of Current Research in Clinical Cancer. 2025;5(1):232-242. doi:10.51847/ea665c6fiw

BibTeX
@article{Chen2025,
  author = {Chen, Wei and Zhang, Li},
  title = {Real-World Effectiveness of Anti–PD-1 Immunotherapy Combined with Definitive Chemoradiotherapy in Inoperable ESCC: A Multicenter Weighted Analysis},
  journal = {Asian Journal of Current Research in Clinical Cancer},
  year = {2025},
  volume = {5},
  number = {1},
  pages = {232--242},
  doi = {10.51847/ea665c6fiw}
}
Kostenlos starten →